DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus
- 1 May 1995
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 115 (1) , 99-105
- https://doi.org/10.1016/0021-9150(94)05504-c
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitusClinical Genetics, 2008
- Apolipoprotein B gene DNA polymorphisms are associated with macro‐ and microangiopathy in non‐insulin‐dependent diabetes mellitusClinical Genetics, 1993
- Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitusAtherosclerosis, 1993
- Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.BMJ, 1991
- Lipoprotein and hepatic lipase gene variants in coronary atherosclerosisAtherosclerosis, 1990
- DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjectsAtherosclerosis, 1989
- Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetesDiabetologia, 1989
- Human genes involved in lipolysis of plasma lipoproteins: Mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21Genomics, 1987
- Human Lipoprotein Lipase Complementary DNA SequenceScience, 1987
- Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapyDiabetes, 1986